PDB36 Reduced Rates of Hypoglycemia Lead to Cost Savings for Type 2 Diabetic Patients Treated with Saxagliptin Versus Sulphonlyurea in Actual Clinical Practice
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.957
https://www.valueinhealthjournal.com/article/S1098-3015(12)01022-4/fulltext
Title :
PDB36 Reduced Rates of Hypoglycemia Lead to Cost Savings for Type 2 Diabetic Patients Treated with Saxagliptin Versus Sulphonlyurea in Actual Clinical Practice
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01022-4&doi=10.1016/j.jval.2012.03.957
First page :
A177
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
456